1. Pharmacometrics for Regulatory Decision Making

   • Efthymios Manolis
   • Ralf Herold

   Commentary 13 September 2012 Pages: 625 - 626

2. Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

   • Joo Yeon Lee
   • Christine E. Garnett
   • Hao Zhu

   Current Opinion 13 September 2012 Pages: 627 - 635

   

3. Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid

   • Keith A. Rodvold
   • Jomy M. George
   • Liz Yoo

   Review Article 13 September 2012 Pages: 637 - 664

   

4. A Single-Species Approach Considering Additional Physiological Information for Prediction of Hepatic Clearance of Glycoprotein Derivate Therapeutics

   • Patrick Poulin

   Original Research Article 13 September 2012 Pages: 665 - 674

   

5. Rivaroxaban

   • Wolfgang Mueck
   • Anthonie W. A. Lensing
   • Frank Misselwitz

   Original Research Article 13 September 2012 Pages: 675 - 686

   

6. Erratum to: Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation

   • E. D. Lobo
   • T. Quinlan
   • M. Heathman

   Erratum 13 September 2012 Pages: 687 - 688